Daiwa Securities Group Inc. Crispr Therapeutics Ag Transaction History

Daiwa Securities Group Inc.

  • $27.1 Billion
  • Q2 2025

A detailed history of Daiwa Securities Group Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 1,800 shares of CRSP stock, worth $122,922. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,800
Previous 282 538.3%
Holding current value
$122,922
Previous $10,000 780.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$31.27 - $48.64 $47,467 - $73,835
1,518 Added 538.3%
1,800 $88,000
Q4 2024

Feb 07, 2025
SELL
$38.65 - $55.15 $1,739 - $2,481
-45 Reduced 13.76%
282 $11,000
Q3 2024

Nov 12, 2024
BUY
$44.62 - $62.75 $1,338 - $1,882
30 Added 10.1%
327 $15,000
Q2 2024

Aug 07, 2024
SELL
$51.17 - $68.18 $55,263 - $73,634
-1,080 Reduced 78.43%
297 $16,000
Q1 2024

May 02, 2024
SELL
$60.67 - $89.12 $5,338 - $7,842
-88 Reduced 6.01%
1,377 $94,000
Q4 2023

Jan 31, 2024
SELL
$38.62 - $72.18 $7,646 - $14,291
-198 Reduced 11.91%
1,465 $92,000
Q2 2023

Jul 31, 2023
BUY
$43.47 - $67.77 $58,597 - $91,353
1,348 Added 427.94%
1,663 $93,000
Q4 2022

Feb 06, 2023
BUY
$39.19 - $65.67 $1,018 - $1,707
26 Added 9.0%
315 $13,000
Q2 2022

Aug 09, 2022
SELL
$43.23 - $73.83 $70,205 - $119,899
-1,624 Reduced 84.89%
289 $18,000
Q1 2022

Apr 29, 2022
BUY
$53.19 - $79.24 $28,190 - $41,997
530 Added 38.32%
1,913 $120,000
Q4 2021

Feb 03, 2022
BUY
$70.09 - $111.29 $38,409 - $60,986
548 Added 65.63%
1,383 $105,000
Q3 2021

Nov 05, 2021
BUY
$110.2 - $156.64 $75,597 - $107,455
686 Added 460.4%
835 $93,000
Q1 2021

May 03, 2021
BUY
$110.72 - $210.04 $1,771 - $3,360
16 Added 12.03%
149 $18,000
Q4 2020

Feb 04, 2021
SELL
$79.67 - $173.23 $20,315 - $44,173
-255 Reduced 65.72%
133 $20,000
Q3 2020

Nov 02, 2020
BUY
$78.5 - $100.64 $4,082 - $5,233
52 Added 15.48%
388 $32,000
Q4 2019

Jan 31, 2020
SELL
$36.68 - $73.13 $440 - $877
-12 Reduced 3.45%
336 $19,000
Q3 2019

Nov 04, 2019
BUY
$40.99 - $52.56 $655 - $840
16 Added 4.82%
348 $14,000
Q1 2019

Apr 26, 2019
BUY
$28.02 - $40.87 $2,185 - $3,187
78 Added 30.71%
332 $12,000
Q1 2018

May 02, 2018
BUY
$23.52 - $58.17 $5,974 - $14,775
254 New
254 $12,000

Others Institutions Holding CRSP

# of Institutions
535
Shares Held
68.7M
Call Options Held
3.67M
Put Options Held
2.25M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $5.33B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email